Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100664532 | 10066453 | 2 | F | 201308 | 20140721 | 20140401 | 20150331 | PER | PHEH2013US010572 | NOVARTIS | 84.00 | YR | M | N | 0.00000 | 20150204 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100664532 | 10066453 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | 2522B | 22083 | |||||||||||
| 100664532 | 10066453 | 2 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | TABLET | |||||||||||
| 100664532 | 10066453 | 3 | SS | NAMENDA | MEMANTINE HYDROCHLORIDE | 1 | ORAL | N | 0 | ||||||||||
| 100664532 | 10066453 | 5 | C | MULTIPLE VITAMINS (ASCORBIC ACID, ERGOCALCIFEROL, FOLIC ACID, RETINOL, TOCOPHEROL, VITAMIN B NOS) | 2 | 0 | |||||||||||||
| 100664532 | 10066453 | 7 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 100664532 | 10066453 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 100664532 | 10066453 | 11 | C | B COMPLEX (NICOTINAMIDE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN, THIAMINE HYDROCHLORIDE) | 2 | 0 | |||||||||||||
| 100664532 | 10066453 | 13 | C | LISINOPRIL (LISINOPRIL) | LISINOPRIL | 1 | 0 | ||||||||||||
| 100664532 | 10066453 | 15 | C | KLONOPIN | CLONAZEPAM | 1 | 0 | ||||||||||||
| 100664532 | 10066453 | 17 | C | TAMSULOSIN (TAMSULOSIN) | TAMSULOSIN | 1 | 0 | ||||||||||||
| 100664532 | 10066453 | 19 | C | LORAZEPAM (LORAZEPAM) | LORAZEPAM | 1 | 0 | ||||||||||||
| 100664532 | 10066453 | 21 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 100664532 | 10066453 | 23 | C | OMPERAZOL ^ACYFABRIK^ (OMEPRAZOLE) | 2 | 0 | |||||||||||||
| 100664532 | 10066453 | 25 | C | POLYETHYLENE GLYCOL (MACROGOL) | 2 | 0 | |||||||||||||
| 100664532 | 10066453 | 27 | C | BABY ASPIRIN (ACETYLSALICYLIC ACID) | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100664532 | 10066453 | 1 | Dementia |
| 100664532 | 10066453 | 2 | Autonomic seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100664532 | 10066453 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100664532 | 10066453 | Application site erythema | |
| 100664532 | 10066453 | Application site pruritus | |
| 100664532 | 10066453 | Application site rash | |
| 100664532 | 10066453 | Chapped lips | |
| 100664532 | 10066453 | Depression | |
| 100664532 | 10066453 | Drug administration error | |
| 100664532 | 10066453 | Dry mouth | |
| 100664532 | 10066453 | Headache | |
| 100664532 | 10066453 | Hypersensitivity | |
| 100664532 | 10066453 | Lip swelling | |
| 100664532 | 10066453 | Nausea | |
| 100664532 | 10066453 | Paraesthesia | |
| 100664532 | 10066453 | Skin discolouration | |
| 100664532 | 10066453 | Skin disorder | |
| 100664532 | 10066453 | Skin haemorrhage | |
| 100664532 | 10066453 | Skin irritation | |
| 100664532 | 10066453 | Skin reaction | |
| 100664532 | 10066453 | Speech disorder | |
| 100664532 | 10066453 | Throat tightness | |
| 100664532 | 10066453 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 100664532 | 10066453 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100664532 | 10066453 | 1 | 20130605 | 0 | ||
| 100664532 | 10066453 | 1 | 20131024 | 0 |